https://doi.org/10.1056/NEJMoa2513525
1h ago
Source
bskyhttps://doi.org/10.1056/NEJMoa2513525doi.orgPhase 1-2 study: BioVAT from iPSC-derived cardiomyocytes boosts heart function in patients with ≤35% LVEF. Engineered muscle offers hope! PMID:42202318, N Engl J Med 2026, @NEJM #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
You might also wanna read
AI talent demand surges 69% as remote six-figure careers expand
Demand for AI talent is surging, with AI-skilled roles up 69% — nearly eight times faster than the overall job market. As companies integrat
forbes.com·53m agoSpain’s Green Power Boom Becomes an Investor Bust
bloomberg.com·1h ago
How to Submit a Public Comment on the Proposed Federal Grant Rule - Solve ME/CFS Initiative
solvecfs.org·1h ago
The war against ‘woke’ could end US science as we know it
theverge.com·1h ago
Trump administration permitting delays threaten 92 GW of clean energy capacity, study finds
A new Wood Mackenzie study reveals that permitting delays and federal funding withdrawals under the Trump administration threaten 92 GW of n
techcrunch.com·1h agoIran’s Oil Money Is Coming Back. Its Main Street Will Have to Wait.
on.wsj.com·1h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.